跳至主要内容
临床试验/NCT04677751
NCT04677751招募中不适用

Clinical and Electrographic Changes in RNS System Patients with Acupuncture Treatment

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
2
主要终点
Percent change in number of disabling clinical seizures

研究概览

简要总结

The purpose of this study is to determine effects of Acupuncture on a Patient's mood and cognition,evaluate changes in clinically-reported seizure frequency and severity and analyze effects of Acupuncture on electrographic epileptiform activity stored by the RNS System

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
15 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patient implanted with the RNS system
  • Patient can undergo 12 weeks of acupuncture
  • Patient is able remain on stable medications for 12 weeks
  • Patient is able to remain on stable Detection and Stimulation settings for 12 weeks
  • Patient or/and caregiver is able to understand and sign informed consent and HIPAA authorization
  • Patient or caregiver able to maintain a seizure diary for duration of study

排除标准

  • Patient and /or caregiver is unable to sign informed consent to study
  • Patient has a bleeding disorder, pacemaker, or pregnant

结局指标

主要结局

Percent change in number of disabling clinical seizures

时间窗: Baseline,12 weeks post treatment

This will be measured by self reporting journals

Changes in seizure severity

时间窗: Baseline,12 weeks post treatment

This will be measured by self reporting journals

次要结局

  • Average number of detections of seizures per-day (as stored by the RNS System)(1 month after last treatment)
  • Change in cognition and mood as assessed by the Quality Of Life In Epilepsy (QOLIE-10) questionnaire(Baseline,12 weeks post treatment)
  • Change in cognition and mood as assessed by the Generalized Anxiety Disorder 7-item (GAD-7) scale(Baseline,12 weeks post treatment)
  • Change in cognition and mood as assessed by the Patient Health Questionnaire (PHQ-9)(Baseline,12 weeks post treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Olga Rodziyevska

Physician Assistant

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验